Last edition
News about "biosimilar immuno-oncology "
Dr. Reddy's launches NIVORZ in India
Dr. Reddy’s has launched NIVORZ, a nivolumab biosimilar in India, marking its entry into biosimilar immuno-oncology with approval across 12 cancer indications.
Biosimilar Immuno-oncology | 16/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members